Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Masahiko Nakayama"'
Publikováno v:
Parkinson's Disease, Vol 2023 (2023)
Prescription doses of levodopa in patients with advanced Parkinson’s disease (PD) are generally lower in Japan than in the United States or Europe, although Japanese guidelines for the management of PD recommend increasing the dosage as the disease
Externí odkaz:
https://doaj.org/article/580a6c22e5b04ce5a09deb4c9b76aaaf
Autor:
Shinichiro Kobayashi, Kengo Kanetaka, Yasuhiro Nagata, Masahiko Nakayama, Ryo Matsumoto, Mitsuhisa Takatsuki, Susumu Eguchi
Publikováno v:
BMC Surgery, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Regardless of developments in thoracoscopic esophagectomy (TE), postoperative complications relative to gastric conduit reconstruction are common after esophagectomy. The aim of the present study was to evaluate the predictive fac
Externí odkaz:
https://doaj.org/article/8619be5e426743d89d142271cce12a95
Autor:
Ulrike Schaede, Jörg Mahlich, Masahiko Nakayama, Hisanori Kobayashi, Yuriko Takahashi, Katsuhiko Saito, Hiroji Uemura, Masayuki Tokumitsu, Kazutake Yoshizawa
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-9 (2017)
This article adds the Japanese perspective to our knowledge of shared decision-making (SDM) preferences by surveying patients with prostate cancer (PCA) and physicians in Japan. In 2015, 103 Japanese patients with PCA were asked about their SDM prefe
Externí odkaz:
https://doaj.org/article/dba53e73c71a471ab774eb2ad92c4657
Autor:
Masahiko Nakayama, Hisanori Kobayashi, Masateru Okazaki, Keiichiro Imanaka, Kazutake Yoshizawa, Jörg Mahlich
Publikováno v:
American Journal of Men's Health, Vol 12 (2018)
The purpose of the present study is to investigate the concordance of treatment preferences between patients and physicians in prostate cancer (PCa) in Japan. An internet-based discrete choice experiment was conducted. Patients and physicians were as
Externí odkaz:
https://doaj.org/article/75114d80dd4c4c9d97be5d642a44b1bc
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195789 (2018)
BACKGROUND:Limited availability of real-world data that describe treatment patterns of Japanese prostate cancer (PCA) patients. METHODS:A biweekly transition analysis of PCA treatment was performed for patients with PCA diagnosis and a specific treat
Externí odkaz:
https://doaj.org/article/ed1414b6aa4f4f2db2acc2d0f6086bff
Publikováno v:
Dermatology and Therapy. 12:1383-1396
Treatment satisfaction in patients with atopic dermatitis (AD) has been investigated in several studies, but the desire for alternative treatment options is unclear and has not been previously evaluated. We conducted a cross-sectional, web-based surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ef30df1794320b10377309eec8fcb6c
https://doi.org/10.1007/s13555-022-00738-6
https://doi.org/10.1007/s13555-022-00738-6
Autor:
Chikashi Yoshida, Takeshi Kondo, Tomoki Ito, Masahiro Kizaki, Kazuhiko Yamamoto, Toshihiro Miyamoto, Yasuyoshi Morita, Tetsuya Eto, Yuna Katsuoka, Naoki Takezako, Nobuhiko Uoshima, Kazunori Imada, Jun Ando, Takuya Komeno, Akio Mori, Yuichi Ishikawa, Atsushi Satake, Junichi Watanabe, Yoshiko Kawakami, Tetsuo Morita, Ikue Taneike, Masahiko Nakayama, Yinghui Duan, Belen Garbayo Guijarro, Alexander Delgado, Cynthia Llamas, Hitoshi Kiyoi
Publikováno v:
International journal of hematology. 116(1)
Acute myeloid leukemia (AML) predominantly affects elderly adults, and its prognosis worsens with age. Treatment options for patients in Japan ineligible for intensive chemotherapy include cytarabine/aclarubicin ± granulocyte colony-stimulating fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f68115b0b0506e86771994fefa145d36
https://pubmed.ncbi.nlm.nih.gov/35394258
https://pubmed.ncbi.nlm.nih.gov/35394258
Autor:
Masahiko Nakayama, Mitsuhisa Takatsuki, Susumu Eguchi, Fumihiko Fujita, Yusuke Inoue, Kantoku Nagakawa
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 78:738-741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::657db0a05ecf5dd8a29ba02c0a88b966
https://doi.org/10.3919/jjsa.78.738
https://doi.org/10.3919/jjsa.78.738
Autor:
Noriaki Takama, Tomoaki Ishii, Toshimitsu Kato, Masami Murakami, Masahiko Kurabayashi, Masahiko Nakayama, Hiroki Okaniwa
Publikováno v:
Journal of Medical Ultrasonics. 47:641-642
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0a3af9ec970f3178a096571b166e13
https://doi.org/10.1007/s10396-020-01032-8
https://doi.org/10.1007/s10396-020-01032-8
Autor:
Hisanori Kobayashi, Masahiko Nakayama, Koji Fukushima, Tomihiro Takahara, Kazutake Yoshizawa, Yukiko Nishimura
Publikováno v:
Gynecologic Oncology. 143:246-251
Background In clinical practice, 40mg/m 2 of pegylated liposomal doxorubicin (PLD40) has been used as an initial dosage for treating recurrent epithelial ovarian cancer (OC) instead of the recommended dose of 50mg/m 2 (PLD50). However, no robust evid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02577d264d7968ea36f9bc43a836f30a
https://doi.org/10.1016/j.ygyno.2016.08.331
https://doi.org/10.1016/j.ygyno.2016.08.331